Table 2 Treatment-related adverse events
Treatment-related adverse events (%, N = 30) | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|
General | |||
 Nausea | 27 | 0 | 0 |
 Fatigue | 17 | 7 | 0 |
 Fever | 3 | 0 | 0 |
 Emesis | 3 | 0 | 0 |
 Dehydration | 3 | 0 | 0 |
 Anorexia | 7 | 0 | 0 |
 Cough | 3 | 0 | 0 |
 Pain | 3 | 0 | 0 |
 Hypoalbuminemia | 3 | 3 | 0 |
Hematologic | |||
 Anemia | 7 | 0 | 3 |
 Leukopenia | 7 | 3 | 0 |
 Lymphopenia | 3 | 7 | 0 |
 Neutropenia | 7 | 0 | 0 |
 Thrombocytopenia | 3 | 0 | 0 |
Gastrointestinal | |||
 Constipation | 0 | 10 | 0 |
 Flatulence | 3 | 0 | 0 |
 Diarrhea | 3 | 0 | 0 |
Hepatic | |||
 ALT elevation | 10 | 3 | 3 |
 Alkaline phosphatase elevation | 3 | 0 | 0 |
 AST elevation | 3 | 0 | 3 |
Dermatologic | |||
 Injection site reaction | 7 | 0 | 0 |
 Ecchymosis | 3 | 0 | 0 |
 Rash | 3 | 0 | 0 |
Others | |||
 Renal dysfunction | 0 | 3 | 0 |
 Hypoxia | 3 | 0 | 0 |
 Bradycardia | 3 | 0 | 0 |
 Headache | 3 | 0 | 0 |
 Stroke | 3 | 0 | 0 |